By submitting the form, you agree to the terms and conditions of our Confidential Disclaimer.
INVESTMENT HIGHLIGHTS
Long-Term Absolute NNN Sale-Leaseback LUX Diagnostics will be executing a brand new, 20-year absolute triple-net (NNN) lease with zero Landlord responsibilities.
High Yield Investment Listed at an 8.5% cap rate with an annualized net income of $585,432 in year 1 and includes 2.5% annual escalators as a hedge against inflation and higher interest rates.
Mission Critical Real Estate The company has invested approximately $2.5 million in its state-of-the-art facility, allowing it to provide a range of lab testing services to clinicians, businesses, and government agencies.
Strong Corporate Guaranty LUX Diagnostics is a key player in the medical diagnostics industry generating over $12 million in revenue with healthy margins, providing a robust EBITDAR-to-rent coverage ratio of over 5x.
Strategic Location With a population of 365,533 in a 5-mile radius, the property is conveniently located right off I-85 within 10 miles of Downtown Atlanta in a growing medical hub, adjacent to a new Children's Healthcare of Atlanta hospital which is slated to open in the Fall of 2024.
Top Metro The Atlanta MSA has become the 6th largest and is one of the fastest-growing regions in the U.S., with strong economic fundamentals and steady population growth over 1% annually.
Robust Healthcare Market Atlanta’s healthcare real estate market rent increased 6.5% in 2023, and the city is home to several major hospitals, research institutions, and biotech companies, fueling demand for medical office buildings and laboratories.
Opportunity Zone Location The property is strategically located in an Opportunity Zone, offering potential tax advantages for investors.
